cannabidiol oral strip (CBD ODF) / BioNxt - LARVOL DELTA

XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips (Yahoo Finance) - "XPhyto Therapeutics Corp...is pleased to provide an update on the development of its fast-dissolving CBD oral strips. With significant complexities involved in the planning and preparation for the pending human pilot study, the Company is pleased to announce that its European human CBD bioavailability study will commence in January 2022...Pending success in the CBD pilot study, the Company expects to carry out a pivotal clinical study in 2H of 2022."

New trial • CNS Disorders • Epilepsy